Galen shareholders shocked by typo

Shareholders in Galen Holdings, the Belfast pharmaceutical company, must have thought they were being short-changed when they read the company's interim statement. The financial highlights read "final dividend per share up 20 per cent to 0.44p". That looked like bad news. But as they read through the statement relief no doubt set in when it became clear that the highlights should have said interim instead of final. The shareholders can now look forward to a final dividend.